Healio Neurology

12/16/2025

At , safety and efficacy of in early symptomatic disease continued to demonstrate clinical benefit in a long-term extension.

The full dataset were presented by : https://tinyurl.com/3u9bsxhh

Treatment with Kisunla was associated with sustained clinical benefits, specifically less symptom worsening and significant amyloid clearance up to 3 years, in early symptomatic Alzheimer’s disease, according to a presenter at CTAD.“This research supports the potential for Kisunla to del...

12/16/2025

Research from The Hospital for Sick Children - SickKids news offered sobering data on mortality risk in severe forms of .

14.2 per 1,000 person years
7.3 per 1,000 person years

The full dataset were presented at : https://tinyurl.com/zwvjrsdr

American Epilepsy Society

Mortality rates for Lennox Gastaut syndrome and Dravet syndrome, both developmental epileptic encephalopathies, were significantly higher than other forms of epilepsy, according to a poster at the American Epilepsy Society annual meeting. “Developmental epileptic encephalopathies (DEEs) are am...

12/15/2025

At , research from The Hospital for Sick Children - SickKids sheds new light on the elevated mortality risk for those with two encephalitic forms of : https://tinyurl.com/zwvjrsdr

American Epilepsy Society

Mortality rates for Lennox Gastaut syndrome and Dravet syndrome, both developmental epileptic encephalopathies, were significantly higher than other forms of epilepsy, according to a poster at the American Epilepsy Society annual meeting. “Developmental epileptic encephalopathies (DEEs) are am...

12/15/2025

At , research from WVU Rockefeller Neuroscience Institute assessed feasibility of for combing electronic health records of those with to address data gaps that may prevent accurate decision-making: https://tinyurl.com/37cawm7z

American Epilepsy Society

AI-powered registries may improve epilepsy care by extracting data from incomplete medical records, easing the burden on clinicians when decisions are necessary regarding surgical evaluations, data show.“Epilepsy care generates an extraordinary amount of nuanced information — changes in...

12/15/2025

🕎Happy Hanukkah from your friends at Healio! May each night bring you light, love and joy.

12/13/2025

Smarter CME starts here. 💡

Tap in and level up your learning: https://bit.ly/3X9ybIq

12/12/2025

The U.S. Food and Drug Administration has approved inebilizumab-cdon ( , Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis.
We spoke with Dr. Richard Nowak of Yale University to find out more:

Myasthenia Gravis Foundation of America, Inc.

The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according to a press release.The approval came in the wake of the phase 3, double-blind, randomized, placebo-c...

12/12/2025

From UC San Diego researchers, new data show the perils for older adults who are dealing with a combination of and obstructive .

Women seem to be affected to a greater degree than men: https://tinyurl.com/m9zz6d6a

American Academy of Sleep Medicine

Older adults with a combination of insomnia and obstructive sleep apnea demonstrated worse sleep and verbal memory performance, with the effect more pronounced in women than men, data show.“Insomnia and sleep apnea often co-occur in older adults, but their combined impact on cognition has not...

12/12/2025

Although negligible vs. placebo in the first portion of a 16-week phase 2b study, ’s efficacy & safety in with Lewy bodies was revealed in an OLE.

More results from University of Newcastle research at here: https://tinyurl.com/4a7y56s2

Dementia UK
Dementia Alliance International

Treatment with neflamapimod slowed clinical worsening and led to reduced disease-related plasma biomarkers in individuals with dementia with Lewy bodies, according to a speaker at CTAD. “Dementia with Lewy bodies (DLB) is a devastating disease with no approved therapies,” John-Paul Taylor, MBBS,...

12/11/2025

From University of Newcastle researchers, promising news about for treatment of with Lewy bodies.

The full dataset were presented at : https://tinyurl.com/4a7y56s2

Dementia UK
Dementia Alliance International

Treatment with neflamapimod slowed clinical worsening and led to reduced disease-related plasma biomarkers in individuals with dementia with Lewy bodies, according to a speaker at CTAD. “Dementia with Lewy bodies (DLB) is a devastating disease with no approved therapies,” John-Paul Taylor, MBBS,...

12/11/2025

Older adults with a combination of and obstructive are at risk for cognitive issues, particularly in verbal memory.

The effects are more pronounced in women vs. men, according to researchers from : https://tinyurl.com/m9zz6d6a

Older adults with a combination of insomnia and obstructive sleep apnea demonstrated worse sleep and verbal memory performance, with the effect more pronounced in women than men, data show.“Insomnia and sleep apnea often co-occur in older adults, but their combined impact on cognition has not...

12/11/2025

Year-end financial housekeeping for physicians: Simple steps with high impact:

As the calendar year winds down, it’s easy for busy physicians to focus on patient care and holiday plans while deferring personal finance matters.